… update the reader on the epidemiology, pathogenesis, and therapy of HPV infections.
Nonanogenital warts … most cases of nonanogenital warts and for a number of genital warts. Such …

… Evidence-based treatment of genital warts is challenging because of the lack of controlled
trials comparing treatments, especially in pediatric and adolescent populations. This paper …

… genital warts as well as the problems that remain to be faced by health care clinicians and
their patients. Genital warts … of genital HPV infections are unrecognized. Existing therapies for …

After anogenital condylomata and intraepithelial neoplasms are removed, they frequently
recur. Since these lesions are related to papillomaviruses, it has been suggested that latent …

… Data show that approximately 3 to 4 million cases of genital warts in men occur each year, …
these genital warts are diagnosed in men younger than 30 years. In addition to genital warts, …

… Apart from the inconvenience and discomfort of treatment, genital warts inflict substantial …
of genital warts. Costs related to routine screening for cervical cancer, treatment of genital warts…

… The problem is increasing steadily in frequency; data on first-time treatment-seekers for
genital warts, for example, show an increase in presentation of around 500% over the past 3 …

… Genital warts (GWs) are a sexually transmitted disease caused by human papillomavirus (…
Genital warts usually occur about 6–12 months after the first infection with HPV [5]. However, …

… The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection
against genital warts (GW) as well as cervical cancer. Our main question was whether HPV …

… monitor AMR and to inform updates to the treatment guidelines. … and ongoing reduction in
genital warts in both Australian‐… with less than 1% diagnosed with genital warts in 15‐ to 20‐…